Hypertension Drug may hold promise for Alzheimer’s Disease
July 10, 2019
Dallas, TX – According to new research in the American Heart Association’s journal Hypertension, while seeking new treatments to slow the progression of Alzheimer’s disease, researchers found the blood pressure drug nilvadipine increased blood flow to the brain’s memory and learning center among people with Alzheimer’s disease without affecting other parts of the brain.
These findings indicate that the known decrease in cerebral blood flow in patients with Alzheimer’s can be reversed in some regions. However, it is unclear if this translates to clinical benefits. (American Heart Association)
